Office Is Back. Bonus Depreciation Is Back. Are You In?

A MESSAGE FROM THE CEO

October is here, and with it comes an important inflection point not just for markets, but for how we think about deploying capital before year-end.

At Streamline, we’re seeing continued momentum where it matters most: on-the-ground activity, new acquisitions in motion, and investor conversations that are focused, clear, and decisive.

While national headlines still paint a murky picture, real estate that serves essential, in-person demand, like medical and professional office, continues to outperform. And with bonus depreciation back to 100%, the timing for tax-advantaged investing has rarely been more favorable.

Our team is currently advancing multiple new assets. The story remains the same: value-add opportunities, real tenant demand, and value we can create through vertical execution, not wishful thinking.

If you’ve been waiting for clarity, this is your window.

Schedule a call to learn more about our strategy here.

— David J. Hrizak, Chief Executive Officer, The Streamline Companies

---

INVESTOR APPETITE FOR OFFICE IS ROARING BACK

According to JLL, office sales in the first half of 2025 jumped 42% year-over-year. JLL’s office sale transactions outpaced all other major property types, with volume up 110% from the first half of 2024, according to CNBC.

Notable insights:
• $25.9B in office sales closed H1 2025
• High-quality assets ($100M+) surged 130% YoY
• Private capital is leading the charge
• Phoenix and Sun Belt markets are seeing positive absorption

As interest rates stabilize and employers return to the office, capital is moving off the sidelines. And in submarkets with medical, professional, and essential-use demand, office is becoming investable again.

---

AZ BIG MEDIA’S PEOPLE TO KNOW

DAVID NAMES IN 2026 EDITION OF PEOPLE TO KNOW IN CRE

We’re proud to announce that our CEO, David Hrizak, has been named as one of AZ Big Media’s People to Know in Commercial Real Estate for 2026.

This recognition speaks to decades of disciplined execution, trusted relationships, and a consistent focus on outcomes that matter, especially here in Phoenix, where Streamline continues to lead in the value-add office and medical space.

---

SIG III – YOUR NEXT MOVE IN CRE

Streamline Investment Group III (SIG III) remains open for accredited investors seeking a differentiated, tax-advantaged path into real assets.

Fund Highlights:
• 8% Preferred Return
• 1.87x Target Equity Multiple
• ~5‑Year Hold, targeting 15%+ net IRR
• 80/20 Profit Split
• Full vertical integration from acquisition to asset management

Why now?
• Phoenix’s Class B and medical office remain supply-constrained and in demand
• Bonus depreciation is back at 100%, creating a powerful tax benefit
• We’re sourcing value-add assets that offer smart upside 

📞 Book a call with David to learn more about SIG III and what we’re acquiring next.